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1. Introduction 
"Insect vector-borne disease" is the term commonly used to describe an illness/or disease 
caused by an infectious microbe that is transmitted to human by blood-sucking arthropods 
such as mosquitoes (e.g. malaria, dengue fever, yellow fever, encephalitis, filariasis, West 
Nile fever and chikungunya), ticks (e.g. Lyme disease), sandflies (e.g. leishmaniasis), tsetse 
fly (e.g. African trypanosomiasis) and kissing bug (e.g. Chagas disease). These diseases are a 
global problem, represent a significant threat to human health and cause enormous impact 
on economic and social life despite considerable national and international control efforts, 
i.e. malaria alone kills annually around one million peoples (Figure 1 & Table 1) (WHO, 
2004; 2010a). It has been well documented by the World Health Organisation (WHO) and in 
numerous scientific investigations and reports that the use of synthetic insecticides can 
dramatically reduce the risk of insect-vector-borne diseases, particularly in the case of 
malaria (Hemingway and Bates, 2003; WHO, 2006a). Current vector control strategies rely 
heavily on use of insecticides through insecticide-treated nets (ITNs) and indoor residual 
spraying (IRS) for example. Space spraying constitutes the first line of activity in case of 
epidemics. Larval control by using insecticides was a success in the past in eradicating 
malaria in some parts of the world i.e. the Anopheles gambiae Project in Egypt 
(Shousha,1948) but still do not received much interest in the current strategies.  
The current success of IRS and ITNs in reducing malaria, the most deadly vector-borne 
disease, contributed towards the optimism that elimination of this disease as a public health 
problem is a feasible objective (Roberts and Enserink, 2007). Substantial international efforts 
have been made during the last three years enabling distribution to approximately 289 
million ITNs in sub-Saharan Africa, enough to cover 76% of the 765 million people at risk of 
malaria (WHO, 2010). The number of countries that employed IRS as vector control strategy 
increased from 31 in 2007 to 68 in 2009 (WHO, 2010). Further scale up of IRS and ITNs for 
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malaria prevention and vector control is occurring throughout the African continent. 
However, the huge amount of vector control insecticides is used for IRS which represents 
around 90% of the total quantity of the annual global quantity of insecticide utilized for 
vector control (WHO, 2010b; Zaim, 2002; Zaim and Jambulingam, 2004; 2007). 
 
Disease Vector 
Disease burden 
DALYs1 (thousands) 2 
Deaths 
(thousands) 2 
Malaria Anopheles mosquitoes 32 342 838 
African 
Trypanosomiasis 
Tsetse flies 1 409 44 
Leishmaniasis Sandflies 1 486 36 
Japanese encephalitis Culex mosquitoes 790 14 
Dengue Aedes mosquitoes 470 13 
Chagas disease Triatomid bugs 342 10 
Lymphatic filariasis 
Anopheles and Culex 
mosquitoes 
4 879 0 
Onchocerciasis Blackflies 348 0 
1DALYs, disability adjusted life years. 
2Adapted from World Health Organization (WHO), projections of mortality and burden of disease, 
2004-2030, baseline scenario 2008 (see: 
http://www.who.int/healthinfo/global_burden_disease/projections/en/index.html). 
Table 1. The current burden of vector-borne diseases. 
Several insecticides have historically been used for IRS, the first and most well-known being 
Dichloro Diphenyl Trichloroethane (DDT). According to the World Health Organization 
position statement (WHO, 2011), DDT is still needed for vector control simply because in 
some places there is no alternative of equivalent efficacy and operational feasibility. To date, 
no change has been warranted in the existing WHO recommendations on the use of DDT for 
IRS. However, the possible adverse consequences of human exposure to DDT cannot be 
ignored, even with limited evidence, and merit further revision. Yet, pyrethroids (PYs) are 
the most commonly insecticides used for IRS and also are the only compounds currently 
approved by the WHO Pesticide Evaluation Scheme (WHOPES) for ITNs (WHO, 2007). 
Even limited risk assessments undertaken regard to the safety of personal use of ITNs 
suggested a high margin of safety for PYs (Bomann, 1995; Zaim et al., 2000), we do not know 
the real consequences of large scale use of PYs on the environment and human health. 
Indeed in understanding results of these limited risk assessments, it is important to note that 
even the use of mosquito nets is not new, long term use of long-lasting insecticide-treated 
bed nets (LLINs), the new generation of ITNs, and in a large scale community-based 
intervention is a new technology, and some uncertainty remains about the potential for 
health problems i.e. the potential chronic neuro-behavioural toxicity in humans (Kolaczinski 
and Curtis, 2004).  
Realizing a scaling up of the current vector control methodologies could lead to deploy of 
tens of millions of doses of insecticides in the form of ITNs and IRS over millions of homes 
in endemic countries annually. Thus, strategies to ensure a fuller understanding of potential 
health risks induced by massive use of insecticides and to minimize actual and potential 
adverse effects on human health are urgently needed. The risks to public health by 
deployment of DDT or other insecticides must be carefully weighed against the benefits, in 
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this case the prevention of vector-borne diseases. Moreover, there are strong evidences that 
more insect vectors species are becoming resistant to the toxic action of these insecticides 
and through different resistance mechanisms, especially knock-down resistance (kdr) 
mechanism to DDT and pyrethroids (Rivero et al., 2010; Ranson et al., 2011). The spread of 
insecticide resistance vertically to new species and horizontally to new countries poses a 
great danger likely to undermine the contribution of vector control efforts to control of 
diseases. Based on screening scientific evidences from literature review, discussion in this 
chapter, will be focused on current status, benefits, resistance and potential hazardous 
effects on human health of insecticide vectors management.  
 
 
Fig. 1. Death from Vector-Born Diseases (VBD). Source: World Health Organization, Health 
and Environment Linkages Initiative, available at: 
http://www.who.int/heli/risks/vectors/vector/en/index.html 
2. Current status of global insecticides use for insect vectors control 
On average, about 3962 metric tonnes of active ingredient of organochlorines, 795 tonnes of 
organophosphates, 16 tonnes of carbamates and 229 tonnes of pyrethroids were reportedly 
used annually for vector control at the global level during 2006–2007. Compared to previous 
years of 2000 – 2002, the recent global insecticide use for vector control increased by 333.5% 
for organochlorines (DDT) and 224% for carbamates. The trend in the global use of 
insecticides for vector control during 1995 – 2007 is shown in Figure 2.  
Compare to 1990s, there is a global decline trend in DDT use, but still on an average, 40,000 
tonnes of DDT were used annually during 2006 - 2007 for vector control (Figure 2).This is 
similar to the annual amount used during the malaria eradication period of 1955–1970. 
Concerns about the continued use of DDT are fuelled by recent reports of high levels of 
human exposure associated with IRS amid accumulating scientific evidence on chronic 
health effects (Sadasivaiah et al., 2007). However, there was a reduction in the use of 
pyrethroids and organophosphates insecticides. Only 44% and 41% of the total amount of 
pyrethroids and organophosphates used in 2000-2002 were applied during 2006-2007, 
respectively (Table 2). Overall, there was a great reduction in use of active ingredient of 
organochlorines, organophosphates, and carbamates during 2000s compared with 1990s. In 
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contrast, the use of pyrethroids increased sharply during 2001-2003, corresponding to the 
period of scaling up of the old generation of ITNs, which required re-treatment by 
pyrethroids insecticide every six months.  
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1 (Data source: Zaim, 2002; Zaim and Jambulingam, 2004; 2006; Ameneshewa et al., 2009). 
Fig. 2. Trend in the global use of insecticides for vector control reported to WHOPES, by 
class of insecticide, 1995–2007.1 
During 2006–2007, about 90% of the total quantity of all classes of insecticides was 
reportedly used for IRS for vector control, followed by space spraying (4%), larviciding 
(3.8%), treatment of mosquito nets (0.3%) and other applications (0.6%). 
 
Year 
Insecticide 
Class2 
WHO region 
African Americas
Eastern 
Mediterranean
European
South-
East Asia
Western 
Pacific 
All 
regions 
2000-2002 OC 307 445 725 0 0 879 761 0 1 187 931 
 OP 34 170 358 136 58 988 6 660 1 482 000 6 205 1 946 158 
 C 331 2 811 1 481 133 1 237 0 6 993 
 PY 2 688 460 940 7 901 1 278 17 257 29 071 519 134 
2003-2005 OC 546 909 0 0 0 0 0 546 909 
 OP 11 707 367 827 21 148 3 317 24 554 8 686 437 239 
 C 20 307 2 681 622 0 1 920 0 24 230 
 PY 13 606 91 948 15 375 1 411 9 979 29 553 161 872 
2006-2007 OC 755 179 0 0 0 3 206 931 9 3 962 118 
 OP 6 403 466 233 52 398 1 620 226 951 41 265 794 868 
 C 6 137 781 7 148 1 076 520 0 15 662 
 PY 6 616 108 450 26 802 3 228 28 927 54 891 228 913 
1 (Data source: Zaim, 2002; Zaim and Jambulingam, 2004; 2006; Ameneshewa et al., 2009). 
2 OC= Organochlorines exclusively DDT; OP= Organophosphates; C= Carbamates; PY= Pyrethroids. 
Table 2. Global use of insecticides for vector control reported to WHOPES, in kg of active 
ingredient, by class of insecticides and WHO region, 2000–2007.1 
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While the same order of application methods was also reported for 2003–2005, there was a 
marked increase in the proportion of insecticides used for IRS (from 60%) and a marked 
decrease in the proportion of insecticides used for space spraying (from 30.7%). There was 
also reduction in the annual insecticide used for larviciding in 2007 compared with 2000 
indicating decrease of interest in relaying on use of these methods for vectors controls  
(Table 3).  
 
Type of 
application 
Insecticide 
Class 
Amount of insecticide used (kg active ingredient) 
 
2000 2001 2002 2003 2004 2005 2006 2007 
IRS OC 2 921 050 291 800 350 941 423 868 389 210 827 648
4 232 
505 
3 691 
730 
 OP 4 263 167 184 782 70925 48 312 32 070 91 232 323 706 583 548 
 C 9 472 4 007 5 277 6 242 4 417 61 235 17 798 11 761 
 PY 96 413 96 402 659 458 82 164 71 183 55 128 122 957 121 912 
ITN PY 43 650 18 253 9 426 15 838 4 694 31 819 6 989 21 412 
Larviciding OP 245 556 112 871 123 659 90 725 89 426 83 136 187 935 189 518 
Space 
spraying 
OP 238 929 246 271 324 741 84 243 311 948 473 994 106 643 173 736 
PY 51 090 57 718 56 604 49 675 50 336 98 021 41 233 94 219 
Other 
applications 
OP N.A2 N.A N.A N.A N.A N.A 12 682 10 717 
 C N.A N.A N.A N.A N.A N.A 1 019 746 
 PY N.A N.A N.A N.A N.A N.A 22 182 10 131 
1 (Data source: Zaim and Jambulingam, 2004; 2006; Ameneshewa et al., 2009). 
2N.A= Data is not available 
Table 3. Recent use of insecticides for vector control reported to WHOPES, in kg of active 
ingredient, by type of application and class of insecticide, 2000–2007.1  
The use of organochlorines at global level was reportedly limited only to IRS and the 
increased reported during 2007 was 126.4% compared with 2000. Except for a report from 
India on the use of hexachlorocyclohexane (HCH) in 2000, DDT has been the only 
organochlorines insecticide reportedly used at global level annually for vector control (Zaim 
and Jambulingam, 2004). This is in agreement with the current approval by WHOPES of 
insecticides recommended for IRS (Table 4). The organochlorines insecticide had been 
intensively applied during 1990s and the amount used during this period was more than 
5000 metric tonnes of DDT active ingredient, and then decreased to its minimum level (500 
metric tonnes) during 2003-2005. Now vectors control activities relayed heavily on the use of 
pyrethroids insecticides for ITNs and IRS. The use of organochlorines raised slightly again 
after reintroduction of DDT in 2005 for malaria vector control in several countries of Africa.  
Carbamates were mainly used for IRS (94%) and in smaller quantity for other applications 
(6%) such as dusting, painting and peri-focal treatment. Of the total annual use of 
organophosphates during 2006-2007, 57% was used for indoor residual spraying, 23.8% for 
larviciding, 17.7% for space spraying and 1.5% for other applications. While about 55.5% of the 
total use of pyrethroids was for indoor residual spraying and 30.7% for space spraying, 6.4% 
was used for treatment of mosquito nets and 7.3% for other applications. In general, the use of 
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pyrethroids for IRS was increased by 126.5% in 2007 compared with 2000. Interestingly, 
despite the numerous scaling up and the high coverage achieved, there was a reduction of 
almost 50% in the annual use of pyrethroids insecticides for treatment of nets in 2007 
compared with 2000. This is due to the starting use of the new generation of net, the long 
lasting insecticidal nets (LLINs) in 2006. LLINs are nets treated in the factory with an 
insecticide incorporated into the net fabric which makes the insecticide last at least 20 washes 
in standard laboratory testing and three years of recommended use under field conditions. 
LLINs are being promoted by WHO and Roll Back Malaria partners as a cost effective and 
sustainable method for protection against malaria. With LLINs therefore the enormous 
amount of insecticides requested for retreating old nets is no longer needed.  
2.1 Insecticides recommended for IRS 
Indoor residual spraying (IRS) is a major intervention for malaria control (WHO, 2006b). 
There are currently 12 insecticides recommended for IRS, this includes 1 organochlorine, 3 
organophosphates, 2 carbamates and 6 pyrethroids insecticides. The only insecticide 
approved for vector control from organochlorines is DDT. Dosage, toxicity, WHO hazard 
classification and registration status of DDT and other insecticides recommended for IRS, at 
U.S Environmental Protection Agency (EPA) are shown in Table 4.  
 
Insecticide compounds 
and formulations2 
Class 
group3
Dosage 
(g a.i./m2)
Oral toxicity for 
rats 
(LD50 of a.i. 
mg/kg) 
Duration of 
effective action 
(months) 
WHO 
Class4 
EPA 
Status5 
DDT WP OC 1-2 113 >6 II Cancelled 
Malathion WP OP 2 2100 2-3 III Active 
Fenitrothion WP OP 2 503 3-6 II Active 
Pirimiphos-methyl WP & EC OP 1-2 2018 2-3 III Active 
Bendiocarb WP C 0.1-0.4 55 2-6 II Cancelled 
Propoxur WP C 1-2 95 3-6 II Active 
Alpha-cypermethrin WP & 
SC 
PY 0.02-0.03 360 4-6 II Cancelled 
Bifenthrin WP PY 0.025-0.05 56t 3-6 II Active 
Cyfluthrin WP PY 0.02-0.05 250 3-6 II Active 
Deltamethrin WP, WG PY 0.02-0.025 135 3-6 II Active 
Etofenprox WP PY 0.1-0.3 42 3-6 U Active 
Lambda-cyhalothrin WP, CS PY 0.02-0.03 56 3-6 II Active 
1 (Data source: USAID, 2007; WHO, 2009). 
2 CS: capsule suspension; EC = emulsifiable concentrate; SC = suspension concentrate; WG = water 
dispersible granule; WP = wettable powder.  
3 OC= Organochlorines; OP= Organophosphates; C= Carbamates; PY= Pyrethroids. 
4 II: Moderately Hazardous; III: Slightly Hazardous; U: Unlikely to present acute hazard in normal use.  
5 U.S Environmental Protection Agency (EPA) registration status. 
Table 4. WHO recommended insecticides for IRS against malaria vectors.1 
2.1.1 History of DDT use in IRS 
DDT (bis[4-chlorophenyl]-1,1,1-trichloroethane, or dichlorodiphenyl trichloroethane) was 
the first synthetic pesticide of the modern age. It promised much, but ultimately created 
widespread concern as an environmental hazard. It was first synthesised in 1874, and its 
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insecticidal properties were described by Paul Müller in the late 1930s (WHO, 1979). 
Commercial sales began in 1945, and DDT became widely used in agriculture to control 
insects, such as the pink boll worm on cotton, codling moth on deciduous fruit, Colorado 
potato beetle, and European corn borer. The compound was also used in sylviculture and, in 
a powder form, as a directly applied louse-control substance in people. In the USA, use of 
DDT rose until 1959 (35 771 tonnes), after which it declined gradually (11 316 tonnes in 1970) 
(WHO, 1979, ATSDR, 2002; Turusov et al., 2002). 
DDT was the first compound used in IRS to protect people against malaria, typhus, and 
other insect vector-borne diseases. Its first attempt was made by the military personnel in 
southern Italy in 1944 and in other parts of the world in the final years of World War II 
(Hays, 2000). Then it was introduced as a vector control measure in civilian populations in 
Guyana, Venezuela, Cyprus and Sardinia (Giglioli et al., 1974; Gabaldon A, 1983). Large-
scale use of DDT for disease vector control was started in 1945 (Hemingway and Ranson, 
2000; Webb, 2011). The early successful campaigns of IRS with DDT against malaria vector 
led to the launch of the Global Malaria Eradication Campaign (GMEC) by WHO in 1955. 
The GMEC was based on the periodic use of IRS with DDT for 3–5 years to interrupt malaria 
transmission. However, weak healthcare systems, insufficient administrative, operational 
constraints, technical capacity, and public reaction to spraying were considered as the major 
factors contributing to the demise of GMEC. Also, population of anopheline resistant to 
DDT was primarily responsible for the dwindling political and financial support for GMEC, 
which ended by 1969 (Litsios, 1996). 
2.1.2 Benefit of DDT use 
Although GMEC did not achieve its ultimate objective, it was credited with eliminating the 
risk of the disease for about 700 million persons, mainly in North America, Europe, the 
former Soviet Union, all Caribbean islands except Hispaniola, and Taiwan (Bruce-Chwatt, 
1980). In these regions, incidence of malaria was reduced to zero, or near zero (Curtis and 
Lines, 2000).  In areas with intense and stable transmission (holoendemic to mesoendemic 
zones) of tropical climates, malaria vectors and prevalence rates were considerably reduced 
during these projects (e.g., in Cameroon, Kenya, Liberia, Nigeria, Senegal, and Tanzania) 
(Kouznetsov, 1977; Curtis and Mnzava, 2000; Mabaso et al., 2004).  DDT is therefore credited 
with wholesale suppression and even complete disappearance of vector species such as 
Anopheles sergenti and Anopheles funestus from sizeable areas of Egypt, South Africa, 
Madagascar and Mauritius (Pampana, 1963; Curtis and Lines, 2000). Unfortunately, few 
African countries participated in the GMEC and even so, the reductions obtained were not 
sustained after the eradication period because limited resources were devoted to malaria 
control (Rogan and Chen, 2005; Sadasivaiah et al., 2007). 
2.1.3 Environmental risk of DDT use 
DDT is a persistent insecticide, does not occur naturally in the environment and is usually 
found as a white, crystalline, tasteless, almost odorless, and enters terrestrial and aquatic 
environments through deposition and accidental spillage. Once DDT enters the terrestrial 
environment, it has a strong affinity for soil and generally remains in the surface layers. As a 
result of this strong affinity for soil, DDT is quite a persistent pollutant. DDT has a half-life 
of 15 years, which means if you use 100 kg of DDT, it will break down to 0.39 kg after 120 
years (Mader, 1996). This also means that after 100 years, there will still be over a pound of 
DDT in the environment. DDT has some potential to bio-accumulate in marine life because 
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it is absorbed by small organisms, such as plankton and fish. It can accumulate to high levels 
in fish and marine mammals (such as seals and whales), reaching levels thousands of times 
higher than in water. In these animals, the highest levels of DDT are found in their adipose 
tissue (ATSDR, 2002). With the publication of “Silent Spring” by Rachel Carson in 1962, the 
safety of DDT for human health and the environment was challenged. This was largely 
based on the ecological considerations, including persistence in the environment and 
sufficient bioaccumulation and toxic effects to interfere with reproduction in pelagic birds 
(i.e., thinning of eggshell). Between 1940 and 1973, estimates indicated that more than 2 
million tons of DDT were used in the United States, about 80% of them in agriculture, and 
some level of resistance was reported in populations of 98 species of economically important 
insects (Metcalf, 1973). Today, no living organism may be considered free of DDT. It is 
stored in all tissues, but the highest concentration occurs in fats. The half-life of 
dichlorodiphenyldichloroethylene (DDE), a primary metabolite of DDT, is about 11 years to 
disappear from an individual if exposure would totally cease, but that DDE would possibly 
persist throughout the life span (Smith, 1991; Wolff et al., 2000).  
2.1.4 Human health risk from DDT use 
Toxic effects of DDT and its analogues have been extensively studied in laboratory animals. 
People who regularly consumed fish from the American Great Lakes were reported to have 
higher serum DDE concentrations (median 10 µg/L) than those who did not eat fish (5 
µg/L), but they did not show impaired motor function (Schantz et al., 1999), impaired 
executive and visiospatial function, or reduced memory and learning capacity (Schantz et 
al., 2001). However, acute exposure to a high dose of DDT can cause death (Smith, 2001). 
Exposure to DDT or DDE increases liver weight, induces liver cytochrome P450 (CYP) 2B 
and 3A and aromatase (Li et al., 1995; Sierra-Santoyo et al., 2000; You et al., 2001), and 
causes hepatic-cell hypertrophy and necrosis (Smith, 2001). In animal, experimental studies 
confirmed that DDT causes hyperactivity, tremor, and seizures (Rogan and Chen, 2005). The 
compound is carcinogenic in non-human primates in mice and rats, mainly causing liver 
tumours (Takayama, 1999; Smith, 2001).  
In human, DDT use has been considered generally safe. Doses as high as 285 mg/kg taken 
accidentally did not cause death, but such large doses led to prompt vomiting. DDT 
poisoning usually results in paresthesia, dizziness, headache, tremor, confusion, and fatigue 
(Rogan and Chen, 2005). The compound has been reported to affect neurobehavioral 
functions and to be associated with premature births (Van Wendel de Joode et al., 2001; 
Longnecker et al., 2001). Various reproductive and hormonal endpoints have been examined 
in both men and women, and although associations have been recorded, causal links have 
not been confirmed. Data from the US Collaborative Perinatal Project showed correlation 
between preterm delivery and raised concentration of DDE in serum (Torres-Arreola et al., 
2003). It has been suggested that maternal exposure to DDT at levels known to occur from 
IRS could increase preterm birth and shorten duration of lactation (Rogan and Chen, 2005). 
With few studies mainly conducted in North America, it is difficult to predict causal 
relationship of DDT exposure to altered preterm delivery or duration of lactation and 
certainly such findings cannot be extrapolated to other settings like Africa. But if DDT does 
increase preterm birth and shorten lactation in Africa, it will increase infant mortality. This 
assumption has been seen by Rogan and Chen, (2005) abrogating the benefit of reducing 
infant mortality from malaria. However, better understanding on the consequence of the 
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increase in infant mortality from DDT exposure versus the lives saved from malaria vector 
control should be a matter for future research (Rogan and Chen, 2005). 
Overall human health effects of DDT and DDE most commonly suggested by studies done 
in North America and Europe are: fertility loss, early pregnancy loss,  leukemia, pancreatic 
cancer, neurodevelopmental deficits, diabetes, and breast cancer (Beard, 2006; Chen and 
Rogan, 2003; Cox et al., 2007; Eriksson and Talts, 2000; Garabrant et al., 1992; Ribas-Fito et 
al., 2006; Snedeker, 2001; Venners et al., 2005). In many cases the results have not been 
consistent between these studies, but nevertheless these accumulating reports bear much 
concern, particularly in relation to chronic effects. Breast cancer has been most rigorously 
studied; even though the majority of results showed no causative association with DDT 
exposure (Brody et al., 2007). This concluded that although extensively studied, there is no 
convincing evidence that DDT or its metabolite DDE increase risk of cancer to human 
(Rogan and Chen, 2005). 
2.1.5 Ban of DDT use 
The concerns about human health and environment led to ban of DDT in Sweden in 1970, 
the USA in 1972, and the UK in 1986 (Ratcliffe, 1967; Turusov et al., 2002). The global ban on 
DDT was proposed in 2001 when production and use of DDT are strictly restricted by an 
international agreement known as the Stockholm Convention on Persistent Organic 
Pollutants (Stockholm Convention, 2001). The Convention’s objective is to protect both 
human health and the environment from persistent organic pollutants. DDT is one of 12 
chemicals identified as a persistent organic pollutant that the Convention restricts. It has 
been listed in Annex B (Restriction) of the Convention and allowed to be used for disease 
vector control in accordance with Part II of the annex. Parties must register with the 
Secretariat to use DDT for disease vector control and comply with specific information 
collection requirements on the production and use of DDT. In May 2007, 147 countries were 
parties to the Convention.  
2.1.6 Re-introduction of DDT use 
When DDT was officially banned in the US in 1972, the WHO reported and concluded that 
the benefits derived from use of this pesticide were far greater than its possible risks (WHO, 
1973). After 35 additional years, these benefits of DDT can be confirmed. In 2000s, several 
countries in sub-Saharan Africa claimed that DDT was still needed as a cheap and effective 
means for vector control (Turusov et al., 2002; Rogan and Chen, 2005). The Convention has 
given an exemption for the production and public health use of DDT for indoor application 
to insect vector-borne diseases, mainly because of the absence of equally effective and 
efficient alternatives. According to the WHO Position Statement (WHO, 2011), DDT has  
several characteristics that are of particular relevance in malaria vector control. Among the 
12 insecticides currently recommended for IRS, DDT is the one with the longest residual 
efficacy when sprayed on walls and ceilings (6–12 months depending on dosage and nature 
of substrate). In similar conditions, other insecticides have a much shorter residual efficacy 
(pyrethroids: 3–6 months; organophosphates and carbamates: 2–6 months). Depending on 
the duration of the transmission season, the use of DDT alternatives might require more 
than two spray cycles per year, which would be very difficult (if not impossible) to achieve 
and sustain in most settings. DDT has a spatial repellency and an irritant effect on malaria 
vectors that strongly limit human-vector contact. Vector mosquitoes that are not directly 
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killed by DDT but are repelled and obliged to feed and rest outdoors, which contributes to 
effective disease-transmission control.  
There is a general consensus that limited and strictly controlled use of DDT should be 
allowed for public health purposes (Liroff, 2002). This re-entering of DDT is now supported 
by key public health organizations and international development agencies, including the 
WHO, the United States Agency for International Development, and the World Bank 
(Hemingway and Ranson, 2000). Although the Stockholm Convention of 2001 targeted DDT 
as one of twelve persistent organic pollutants for phase-out and eventual elimination, it 
allowed a provision for its continued indoor use for disease vector control. This provision 
was approved without any objection by approximately 150 national delegations (Stockholm 
Convention on Persistent Organic Pollutants, 2001). However, still the possible adverse 
human health and environmental effects of exposure through IRS must be carefully 
weighed against the benefits of DDT as being low-cost antimalarial tool (Sadasivaiah et al., 
2007). WHO has therefore approved the use of DDT under specific condition when “locally 
safe, effective, and affordable alternatives are not available”. WHO points out that DDT 
spraying is “most effective in reducing the overall malaria burden in unstable transmission 
areas, regions with marked seasonal transmission peaks and disease outbreaks, and 
highlands areas” (WHO, 2004). 
In general, the past decade has seen a steady increase in commitment to malaria control by 
the international community (Snow et al., 2008). This has caused a boost in financial and 
human resources available for implementation of vector control interventions, due to the 
support of the Global Fund, the World Bank, the U.S. President’s Malaria Initiative, and 
many non-governmental organizations. China, the Solomon Islands, and Vietnam have 
largely replaced their IRS programs with ITNs during the past decades (Najera and Zaim, 
2001). Conversely, the use of IRS is on the increase in Africa, where it has been more difficult 
to come to grips with malaria because of aspects of vector biology and disease 
epidemiology. IRS with DDT has become part of the national Roll Back Malaria strategic 
plan in several countries in Africa (Mabaso et al., 2004; Sharp et al., 2007; Hougard et al., 
2002). In India, IRS with DDT has been the mainstay of vector control for more than 5 
decades. In general, reports to the WHO showed that the use of DDT for malaria vector 
control increased substantially among the African nations during 2000–2005 (Table 5), but 
decreased almost to zero in the Americas due to the signing of the North American 
Agreement on Environmental Cooperation, a side accord to the North American Free Trade 
Agreement (Sadasivaiah et al., 2007). 
2.2 Pyrethroids compounds used for insecticide-treated nets (ITNs) 
2.2.1 History of ITNs 
A mosquito net offers protection against mosquitoes, flies, and other insects, and thus 
against diseases such as malaria, dengue fever, yellow fever, and various forms of 
encephalitis, including the West Nile virus, if used properly and especially if treated with an 
insecticide, which can double effectiveness. The fine mesh construction stops many insects 
from biting and disturbing the person sleeping under net. The mesh is fine enough to 
exclude these insects, but it does not completely impede the flow of air. A mesh size of 
1.2 mm stops mosquitoes, and smaller, such as 0.6 mm, stops other biting insects such as 
biting midges (no-see-ums). Mosquito netting has a long history. Though use of the term 
dates from the mid-18th century, use of mosquito nets has been dated to prehistoric times. It 
is said that Cleopatra, Queen of Egypt, also slept under a mosquito net. Mosquito nets were  
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 Country    2003    2005    2007    Comment   
 Produce of DDT for vector 
control   
        
 China    450    490    NA    For export   
 India   4,100    4,250    4,495    For malaria and leishmaniasis   
 DPRK    NA    NA    5   
 > 155 metric tons for use in 
agriculture   
 Global production   < 4,550    < 4,740   > 4,500    
 Use of DDT for vector 
control   
        
 Cameroon    0    0    0    Plan to pilot in 2009   
 China    0    0    0    Discontinued use in 2003   
 Eritrea    13    15    15    Epidemic-prone areas   
 Ethiopia    272    398    371    Epidemic-prone areas   
 Gambia    0    0    NA    Reintroduction in 2008   
 India    4,444    4,253    3,413    For malaria and leischmaniasis   
 DPRK    NA    NA    5   
 > 155 metric tons used in 
agriculture   
 Madagascar    45    0    0    Plan to resume use in 2009   
 Malawi    0    0    0    Plan to pilot in 2009   
 Mauritius    1    1    <1   
 To prevent malaria 
introduction   
 Morocco    1    1    0    For occasional outbreaks   
 Mozambique    0    308    NA    Reintroduction in 2005   
 Myanmar    1    1    NA    Phasing out   
 Namibia    40    10    40    Long-term use   
 Papua New Guinea    NA    NA    0    No recent use reported   
 South Africa    54    62    66    Reintroduction in 2000   
 Sudan    75    NA    0    No recent use reported   
 Swaziland    NA    8    8    Long-term use   
 Uganda    0    0    NA   
 High Court prohibited use, 
2008   
 Zambia    7    26    22    Reintroduction in 2000   
 Zimbabwe    0    108    12    Reintroduction in 2004   
 Global use    > 4,953   > 5,210    > 3,950    
1Adapted from van den Berg, 2011. 
Table 5. Annual global production and use of DDT (in 103 kg active ingredient) in 2003, 
2005, and 2007.1  
used during the malaria-plagued construction of the Suez Canal (see History of Malaria 
Control at: http://hub.webring.org/hub/malaria). The mosquito net, while used 
throughout Asia for centuries, was brought into American mainstream by Col. William 
Gorgas during the construction of the Panama Canal when thousands of workers, both local 
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and foreigner, died from the outset of malaria. Mosquito nets treated with insecticides — 
known as insecticide treated nets (ITNs) or bednets — were developed in the 1980s for 
malaria prevention (Hung et al., 2002). Newer, longer lasting insecticide nets (LLIN) are 
starting to replace ITN's in many countries. ITNs are estimated to be twice as effective as 
untreated nets and offer greater than 70% protection compared with no net (Bachou et al., 
2006). These nets are treated using a synthetic pyrethroid insecticide such as deltamethrin or 
permethrin which improve the protection over a non-treated net by killing and repelling 
mosquitoes. At least 6 insecticide products are recommended by WHOPES for impregnation 
of mosquito nets for malaria vector control (Table 6). 
 
Insecticides 
(Formulations1) 
Dosage2 
Relevant 
NOAEL mg 
(a.i./kg bw/day)
ADI mg (safety 
factor of 100) 
Oral toxicity  
LD50 
(mg/kg/bw)  
Dermal 
toxicity 
LD50 
(mg/kg/bw)  
Alpha-cypermethrin  
(SC 10%) 
20-40 1.5 0–0.02 4,932 2,000 
Cyfluthrin (EW 5%) 50 2 0–0.02 2,100 >5,000 
Deltamethrin (SC 1%3)    15-25 1 0–0.01 >10,000 >10,000 
Etofenprox (EW 10%))) 200 3.1 0–0.03 >5,0001 >5,000 
Lambda-cyhalothrin  
(CS 2.5%) 
10-15 2.5 0-0.02 56 632 
Permethrin (EC 10%) 200-500 5 0–0.05 5,000–6,000 4,000–10,000 
1EC = emulsifiable concentrate; EW = emulsion, oil in water; CS = capsule suspension; SC= suspension 
concentrate; WT = water dispersible tablet. 
2Milligrams of active ingredient per square metre of netting 
3 Formulation of WT 25%; and WT 25% + binder (K-O TAB 1-2-3®) are also recommended for this 
insecticide. 
Table 6. WHO recommended insecticide products treatment of mosquito nets for malaria 
vector control. 
2.2.2 Benefit of ITNs use 
The use of ITNs has been shown to be an extremely cost - effective method of malaria 
prevention and are part of WHO’s Millennium Development Goals (MDGs). These nets can 
often be obtained for around $2.50–$3.50 from the United Nations organizations such as 
WHO and UNICEF, including commercial sources, with additional cost on logistics. 
Generally LLIN's are purchased by donor groups like the Bill and Melinda Gates 
Foundation and distributed through in country distribution networks. 
Studies on the cost-effectiveness of free distribution concluded on spill over benefits of 
increased ITN usage (Hawley et al., 2003a). ITNs not only protect the individuals or 
households that use them, but they also protect people in the surrounding community in 
several ways (Maxwell et al., 2002). First, ITNs kill adult mosquitoes, the exposure to 
insecticide directly increases the mortality rate and can therefore decrease the frequency in 
which a person is bitten by an infected mosquito (Killeen and Smith, 2007). Second, certain 
malaria parasites require several days to develop within the salivary glands of the vector 
mosquito. Plasmodium falciparum, the parasite responsible for the majority of deaths in sub-
Saharan Africa, takes 8 days to mature and therefore malaria transmission to humans does 
not take place until approximately the 10th day, although would have required blood meals 
at intervals of 2 to 5 days (Smith and McKenzie, 2004). By killing mosquitoes prior to 
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maturation of the malaria parasite, ITNs can reduce the number of encounters of infected 
mosquitoes with humans (Killeen and Smith, 2007). When a large number of nets are 
distributed in one residential area, their insecticidal additives effect helps to reduce the 
density of mosquitoes in the environment. With fewer mosquitoes in the environment, the 
chances of malaria infections are significantly reduced. A review of 22 randomized 
controlled trials of ITNs (Lengeler, 2004) found that ITNs can reduce deaths in children by 
one fifth and episodes of P falciparum malaria by half. More specifically, in areas of stable 
malaria "ITNs reduced the incidence of uncomplicated malarial episodes by 50% compared 
to no nets, and 39% compared to untreated nets" and in areas of unstable malaria "by 62% 
compared to no nets and 43% compared to untreated nets". As such the review calculated 
that for every 1000 children protected by ITNs, 5.5 lives would be saved each year. 
Despite, the wide acceptance and significant efforts made for scaling up ITNs in Africa 
(WHO, 2002) questions concerning the long-term acceptability and durability of this 
strategy are still remaining. First, reductions in all-cause child mortality rates due to short-
term effect related to use of nets may not be sustainable, because initial reductions in 
mortality occur as a result of the combination of reduced malaria transmission and pre-
existing partial immunity developed under the formerly higher levels of transmission. After 
transmission declines and immunity wanes, mortality rates may increase (Molineaux, 1997). 
Second, pyrethroid resistance in Anopheles mosquitoes might compromise the long-term 
effectiveness of ITNs in killing mosquitoes (Zaim and Guillet, 2002). Third, it is not clear 
whether the community will maintain proper use of nets and sustain (adherence) over long 
periods, particularly when nets are distributed free of charge (Curtis et al., 2003). Fourth, 
acquired immunity against clinical malaria, a function of the frequency of infections, is 
delayed as it is developing gradually with time. Therefore, the period during which a child 
is at risk from clinical malaria might increase where ITNs are used (Snow and Marsh, 1995; 
Trape and Rogier, 1996). The practical impact of this hypothesis is that: if a child was 
protected by ITNs but later these were no longer provided or were not used, there might be 
a rebound effect of clinical disease when the child is exposed to infectious mosquitoes.  
Some of carefully controlled efficacy trials that have been running up to 6 years period have 
shown the benefit of using ITNs in Africa. Results of research project in western Kenya, using 
randomized controlling trials, showed that ITNs use led to: First, 90% reductions in malaria 
vector population (Gimnig et al., 2003), 74% reduction in force of infection in infants (ter Kuile 
et al., 2003a), and 23% reduction in all-cause mortality in infants (excluding neonates) (Phillips-
Howard et al., 2003a). Second, no evidence for compromised immunologic antibody response 
has been confirmed in children less than five years of age (Kariuki et al., 2003). Third, clear 
beneficial effects on malaria specific morbidity (clinical malaria, malarial anemia) and growth 
in infants and 1–3 year-old children have been confirmed. Fourth, reduction in exposure to 
malaria in infancy does not, with continued use of nets for 22 months, result in increased 
malaria morbidity in one-year-old children (ter Kuile et al., 2003a & b). Fifth, clear reduction in 
visits of sick children to health facilities associated with ITNs use with concomitant reduction 
in quantities of antimalarial drugs prescribed (Phillips-Howard et al., 2003b). Sixth, clear 
benefits associated with pregnancy, including reduced maternal and placental malaria, 
maternal anemia, and low birth weight (for the first four pregnancies) (ter Kuile et al., 2003b). 
Seventh, beneficial effects of ITNs spill over into areas adjacent to villages with ITNs; 
magnitude of this community mass effect is similar to that observed within ITNs villages and 
dependent upon coverage i.e. the proportion of houses in a given area with ITNs (Hawley et 
al. 2003; Gimnig et al., 2003). Eighth, evidence for the existence of a community-wide effect due 
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to marked reduction in vector populations (Howard et al., 2000; Hii et al., 2001; Maxwell et al., 
2002), implying that ITNs have substantial effects at the population level. Finally, all these 
public health benefits of ITNs were sustained for up to 6 years and there is no evidence that 
bed-net use from birth increases all-cause mortality in older children (Lindblade et al. 2004). 
All these findings have been demonstrated in areas under setting of intense perennial malaria 
transmission. More recently, Fegana et al. (2007) associated ITNs use (67% coverage), under 
different settings of malaria transmission in Kenya, with 44% reduction in mortality in 
children less than five years.  
3. Hazard of pyrethroids insecticides use for ITNs and IRS 
Massive use of ITNs began in 1980s following the developmental of photostable synthetic 
pyrethroids which are faster acting, effective in small quantities, relatively stable adhering 
to fabric, and relatively safe to human (WHO,1999). Scale up of the ITNs usage has emerged 
as a key intervention for malaria control in 2000s. The initial aim of Roll Back Malaria (RBM) 
was to cover 60% of population in malaria endemic countries, which was refined to achieve 
coverage of 2 bed nets per household. In this case millions of people were expected to be 
exposed at different dosages of pyrethroids in malaria endemic countries. Washing large 
quantities of ITNs leading to spill over of insecticide to water bodies could be hazardous to 
both human and aquatic environment. Likewise regular re-treatment and use of nets as well 
as use of LLIN’s increases the risk of acute toxicity among net dippers and regular users. 
Also new technology with potential for malaria prevention, such as insecticide impregnated 
durable wall lining (DL), insecticide treated blankets and tents (e.g. Demuria nets) pre-
treated at the factory with high concentration of insecticide, increase the risk of acute 
toxicity to people doing installation and household occupants coming into contact. In one of 
WHO’s statements regarding the safety of pyrethroid treated mosquito nets (WHO, 1999), it 
was asserted that if prescribed precautions are followed, field use of these products at 
concentrations recommended for treatment of mosquito nets poses little or no hazard to 
people treating the nets or to users of the treated nets. Although other risk assessment of the 
use of deltamethrin on ITNs largely supports this view of the WHO, a relatively high 
chronic risk (beyond the US EPA standard of 0.01 mg. active ingredient/kg/body weight) 
was shown to exist for newborns sleeping under ITNs (Barlow et al., 2001). 
All pesticides are toxic by nature and present risks of adverse effects that depend on toxicity 
of the chemical and the degree of exposure. Toxicity refers to the inherent poisonous 
potency of a compound under experimental conditions, and chronic toxicity refers to the 
potential for adverse effects from long-term exposure (Hirsch et al., 2002). While there is 
agreement that ITNs can be effective in reducing malaria morbidity and mortality under 
field trials, the adverse effects associated with their use at different level of age groups and 
sex has not yet to be fully evaluated. Some scientists raised concerns about the long-term 
effects of ITNs exposures, especially on children and pregnant women (Anyanwu et al., 
2004). In their comprehensive literature review, Anyanwu et al. (2006) show that not much 
work has been done on the effects of long-term exposure to ITNs. But the authors 
surprisingly concluded that the results of their search on the subject to date seem to support 
only the efficacy of the temporal use of plain bed nets, but not the use of ITNs, and do not 
tell much about the long-term effects of ITNs exposure (Anyanwu et al., 2006). Indeed, all 
pesticides are toxic and have both acute and chronic effects (Ratnasooriya et al., 2003). While 
there is no doubt about the effectiveness of ITNs and the main challenge now is to scale up 
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their use (WHO, 2002). Review reports on the benefits of ITNs did not yield any information 
relating to the potential adverse effects of long-term exposure to insecticide treated products 
(Anyanwu et al., 2006). However, Kolaczinski and Curtis (2004) concluded that chronic 
effects can presently not be excluded with certainty, as relevant toxicological data do not 
exist in the open scientific literature. Properly designed neuro-behavioural studies on 
groups with long-term exposure to low doses of synthetic pyrethroids should be conducted 
in order to assess effect of exposure of ITN’s. Meanwhile pyrethroids should continue to be 
used for public health interventions to contribute reducing malaria morbidity and mortality 
reduction, such as ITNs for malaria control. 
On the other hand, IRS insecticides applied indoors of dwellings is subject to a number of 
considerations and constraints. Similar constraints should apply to new technology under 
evaluation, such as the durable wall lining (DL) impregnated with high concentration of 
insecticide, with characteristic of both IRS and LLIN. One of these considerations relates to the 
required residual effectiveness of the insecticide applied to last the malaria transmission 
season (Table 4). It is therefore logical that active ingredients (AIs) used in IRS and DL should 
be biologically available to control the mosquito vectors, but also at the same time potentially 
available for human uptake via various routes. These routes conceivably include dermal 
uptake, inhalation (dust and gas phase), and ingestion. As pointed out elsewhere, there 
probably exists a dynamic redistribution of applied insecticide through a continuous process 
of indoor sublimation, deposition, and revolatilization, as well as dust movement, 
necessitating a total home stead environment approach when considering exposure (Sereda 
et al. 2009). Bouwman and Kylin (2009) showed that infants under malaria control conditions 
are exposed to combinations of chemicals that would have deleterious effects if the intakes 
were high enough. They actually showed that the intakes through breast milk do exceed 
acceptable levels of intake, but they do not attributed the whole level of exposure to 
insecticides used in malaria control i.e. agricultural and home garden use could also contribute 
to the levels in the tissue and in breast milk. Generally, the possible resultant toxicity from this 
exposure could be attributable to either a single compound or combinations of several that 
could act additively, antagonistically, independently, or possibly synergistically. Critical 
windows of exposure also need to be considered. The health effects might be transient, 
reversible, latent, and/or permanent, and might also be subtle and not readily attributable to 
insecticide use for vector control. Given that IRS and ITNs also effectively reduce morbidity 
and mortality of malaria, this resulting in a paradox that is a characteristic of many situations 
where risks and positive outcomes need to be measured and balanced. Because millions of 
people in malaria control areas experience conditions of multiple sources and routes of 
exposure to any number of insecticides, even though lives are saved through malaria 
prevention, identification of potential health risks to infant associated with insecticide residues 
in breast milk must be incorporated in WHOPES evaluations and in the development of 
appropriate risk assessment tools (Bouwman and Kylin 2009). 
4. Insecticide resistance in insect vectors  
Much of the available insecticides for vector control, which have been spectacularly 
successful in the past, are more than 35 years old (Table 7). For example, early efforts to 
control malaria during the 1950s and 1960s with spraying indoors with DDT and other 
insecticides achieved almost total eradication of the vector and the pathogen in many parts 
of the world (Gramiccia and Beales, 1988; Mabaso et al., 2004; Roberts et al., 2000). These 
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efforts simultaneously reduced levels of transmission of dengue, leishmaniasis and filariasis. 
Some countries, such as Taiwan, are now celebrating 40 transmission-free years of malaria. 
This is a massive achievement, as malaria was previously a major killer in the country 
(Hemingway et al., 2006). More recently, ITNs reduced morbidity and also mortality from 
all causes (Phillips-Howard et al., 2003a; Lengeler, 2004). This is a result of protection at the 
levels of the individual and the community (Lindblade et al., 2004). Control of dengue 
vectors relies on the removal of larval breeding containers, such as old tyres or flower vases 
or on insecticide spraying in homes. This approach has been used successfully in some 
locations, but is not sustainable (Rigau-Perez et al., 2002; Gubler, 1989). Due to insecticide 
resistance, legitimate environmental and human health concerns, the use of many older 
generation insecticides, such as DDT is decreasing. The result is that the number of public 
health insecticides available is dwindling and vector-borne disease transmission is 
increasing (Hemingway et al., 2006). 
Resistance is defined as a heritable change in the sensitivity of a population to an insecticide, 
which is reflected in the repeated field failure of that product to achieve the expected level of 
control when used according to the recommendations for that pest species, and where 
problems of product storage, application and unusual climatic or environmental conditions 
can be eliminated (McCaffery and Nauen, 2006). Frequent applications of the same insecticide 
will select for those individuals in a population, with inherent genetic advantage, that are able 
to survive the recommended dose of the compounds. Over time, this selection pressure will 
lead to a resistant population becoming established. In such cases, other compounds within 
the same class of chemistry are in most cases also affected – for instance, resistance to one 
pyrethroid type usually confers resistance against the whole group of pyrethroids, a 
phenomenon known as cross-resistance. Sometimes, depending on the nature of the resistance 
mechanism, cross-resistance can occur between different chemical classes, for example 
organophosphates and carbamates, and cross resistance between DDT and pyrethroids (multi-
resistance). Furthermore, resistance development due to selection pressure in disease vectors is 
sometimes complicated by an additional (perhaps sometimes neglected) aspect: the frequent 
application of similar synthetic insecticides to control pests of agricultural importance. This 
may indirectly affect the susceptibility of insects of public health importance, because that is 
where the vectors are additionally exposed to pesticides used for agricultural purpose 
(Brogdon and McAllister, 1998; Liu et al., 2006; Hemingway and Ranson, 2000; Nauen, 2007). 
4.1 Insecticide resistance mechanisms 
Four classes of chemical insecticides are the mainstay of vector control programmes: namely 
organochlorines, organophosphates, carbamates, and pyrethroids (WHO, 2006a). To date, 
four types of resistance mechanisms against the chemical insecticides have been described: 
metabolic resistance, target site resistance, penetration resistance, and behavioural 
resistance. Metabolic and target site resistance have been extensively investigated at both 
the genetic and molecular levels (Hemingway and Ranson, 2000). Metabolic resistance 
involves the sequestration, metabolism, and/or detoxification of the insecticide, largely 
through the overproduction of specific enzymes (Hemingway and Karunaratne, 1998; 
Hemingway et al., 1998). So far, three main groups of enzymes have been identified in 
different insect vectors species (Table 7): carboxylesterases (EST: efficient against 
organophosphate and carbamate insecticides), glutathione- S-transferases (GST: efficient 
against organophosphates, organochlorine, and pyrethroid insecticides) and cytochrome 
P450-dependent monoxygenases (MOX: efficient against most insecticide types, frequently 
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Years WHO approved insecticides Comments 
1940-45 DDT   
Only a limited 
number of 
insecticide classes 
are available for 
insect vectors 
control. No new 
insect vector 
adulticide has been 
approved by the 
WHO the last 20 
years. 
 
 
 
 
 
 
 
 
 
 
1946-50 Lindane   
1951-55 Malathion   
1956-60    
1961-65 Fenitrothion Propoxure  
1966-70 
Chlorpyrifose-
methyl 
  
1971-75 
Pirimiphose-
methyl 
Bendiocarb Permethrin 
1976-80 Cypermethrin   
1981-85 
Alpha-
cypermethrin 
Cyfluthrin  
 
Lambada-
cyhalothrin 
Deltamethrin Bifenthrin 
1986-90 Etofenprox   
1991-95    
1996-00    
2001-05    
2006-10    
    
  Organochlorines   Carbamates
  Organophosphates   Pyrethroids 
1Adapted from Nauen, 2007. 
Table 7. History of WHO-approved insecticides for adult malaria mosquito control.1  
in conjunction with other enzymes). The overproduction of these enzymes may be achieved 
via two nonexclusive mechanisms: gene amplification increasing the gene’s copy number 
(Hemingway et al., 1998) and gene expression via modifications in the promoter region or 
mutations in trans-acting regulatory genes (Hemingway et al., 1998; Rooker et al., 1996). In 
addition, in some mosquito species, carboxylesterase resistance to the insecticide malathion 
has been associated with a qualitative change in the enzyme (a few amino acid substitutions 
can increase the rate of hydrolysis of the enzyme (Hemingway et al., 2004). In contrast, 
target site resistance is achieved by point mutations that render the actual targets of an 
insecticide less sensitive to the active ingredient (Hemingway and Ranson, 2000; Weill et al., 
2003). Most insecticides developed to date are neurotoxic and aim for one of the following 
three targets: the acetylcholinesterase (AChE) (whose role is the hydrolysis of the 
neurotransmitter acetylcholine), the c-aminobutyric acid (GABA) receptors (chloride-ion 
neurotransmission channels in the insect’s nervous system), or the sodium channels 
(responsible for raising the action potential in the neurons during the nerve impulses). The 
acetylcholinesterase is the target of organophosphorous and carbamate insecticides, the 
GABA receptors are the main targets of cyclodiene (organochlorine) insecticides, and the 
sodium channels (resistance by modification of this site known as knockdown resistance 
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(KDR)) are the targets of pyrethroid and organochlorine insecticides. Mutations in all these 
three sites can confer resistance (Table 8). 
More recently, two alternative insecticide types have been introduced, largely for the control 
of mosquito larvae: bio-pesticides (e.g., Bacillus thuringiensis, Bacillus sphaericus) and 
insect growth regulators, such as the juvenile hormone mimic and methoprene (WHO, 
2006a). Cases of resistance to these alternative insecticides are still limited (Rivero et al., 
2010) and the underlying mechanisms are only beginning to be identified (Chalegre et al., 
2009; Darboux et al., 2007). 
 
Vector Pathogen (Disease) Insecticide Resistance 
  Metabolic  Target Site  
Diptera  
(mosquitoes, flies)  
   
Aedes sp.  
Brugia, Wuchereria (lymphatic 
filariasis), yellow fever virus,  
EST KDR 
 dengue virus, encephalitis virus    
  GST GABA 
Anopheles sp.  
Plasmodium sp. (malaria), 
Wuchereria (filariasis)  
EST KDR 
  GST AChE 
  MOX GABA 
Culex sp.  
Wuchereria (filariasis), West Nile 
virus, encephalitis virus  
EST KDR 
  GST AChE 
  MOX GABA 
Phlebotomus sp.  Leishmania sp. (leishmaniasis)  EST AChE 
Simulium sp.  Onchocerca sp. (river blindness)  EST - 
Haemiptera (true bugs)     
Rhodnius sp.  Trypanosoma sp. (Chagas disease) ? ? 
Triatoma sp.  Trypanosoma sp. (Chagas disease) EST - 
  MOX  
Phiraptera (body lice)     
Pediculus sp.  Rickettsia sp. (epidemic thyphus)  ? ? 
Siphonaptera (fleas)     
Xenopsylla sp.  Pasturella (bubonic plague)  ? ? 
1Adapted from Rivero et al. (2010). 
Metabolic resistance: EST, enhanced esterase activity; GST, enhanced glutatione-S-transferase activity; 
MOX, enhanced p450 monoxygenase activity. Target site resistance: AChE, modification of the 
acetylcholinesterase; GAB, modification of the GABA receptors; KDR, (knockdown resistance) 
modification of the sodium channels. ?, Insecticide resistance present but mechanism unknown or 
unconfirmed to the best of our knowledge.  
Table 8. Insecticide resistance mechanisms reported to date in natural populations of the 
main insect vectors of human diseases1. 
4.2 Resistance and disease control 
To compromise insecticide vector control, the level of resistance must be high enough to 
adversely affect disease transmission. In many cases, vector control may not be affected 
by the level of resistance. For example, an activity may be controlling only 75% of the 
vector population. If, for example, the level of resistance is lower than 10%, resistance will 
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not affect disease control efforts; in this situation, increasing surveillance and monitoring 
level and frequency of resistance would be sufficient. No change in control methods 
would be needed (Brogdon and McAllister, 1998). Western Kenya is a good operational 
example of the coexistence of resistance and disease control. Pyrethroid resistance 
appeared soon after bed nets were introduced in Kenya. After 2 years, the resistance level 
had not changed significantly, possibly because of the continual introduction of 
susceptible genes (Vulule et al., 1996). Other reasons may explain why the presence of 
insecticide resistance genes in vectors in a control area does not mean that effective 
control is not being achieved. For example, resistance genes may not be expressed, they 
may be expressed in an alternative stage of development to that being controlled by 
insecticide, or the gene detected may be a member of an alternative gene subfamily to one 
that can affect the compound being used (Brogdon and McAllister, 1998). For example, in 
An. albimanus, resistance enzymes, especially esterases and GST, may be expressed only in 
freshly emerged adult anophelines and may be absent in older mosquitoes, those 
potentially infectious for malaria (Brogdon et al., 1999). In six populations of An. arabiensis 
from Sudan, the L1014F-kdr resistance allele present in 66% dead individuals against the 
WHO discriminating concentrations of permethrin (Himeidan et al., 2011) suggesting that 
another factor in the para-type sodium channel gene might be needed for the expression 
of kdr resistance phenotype (Brooke, 2008).  
Insecticide resistance is viewed as an extremely serious threat to crop protection and vector 
control, and is considered by many parties, including industry, the WHO, regulatory bodies 
and the public, to be an issue that needs a proactive approach. In 1984, the Insecticide 
Resistance Action Committee (IRAC) was formed in order to provide a coordinated private-
sector response to prevent or at least delay the development of resistance (www.irac-
online.org) (McCaffery and Nauen, 2006). 
The Innovative Vector Control Consortium (IVCC) was formed in 2005, with an initial 
grant of $50.7 million from Bill & Melinda Gates Foundation over five years, as a new 
initiative to enable industry and academia to join forces to improve the portfolio of 
chemical and technological tools available to reduce vector-borne diseases. Since then, an 
unprecedented development pipeline of new, reformulated and repurposed insecticides 
has been established in partnership projects with leading global chemical companies. A 
suite of information systems and diagnostic tools for the more effective and efficient use 
of insecticides has also been developed, with these products now nearing the end of their 
development phase and being readied for rollout in the coming year. Accordingly, IVCC 
has received another $50 million in 2010 from the Bill & Melinda Gates Foundation to 
continue its work to develop new insecticides for the improved control of mosquitoes and 
other insects which transmit malaria, dengue and other neglected tropical diseases. As 
resistance to insecticides is increasing at an alarming rate and it must find new 
alternatives insecticides against malaria vectors and other vector borne diseases, the 
strategic aim of IVCC is to provide three new Active Ingredients for use in public health 
insecticides by 2020. 
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